Dechert LLP’s capital markets team is active on issuer-side engagements in the financial services sector, with notable expertise when it comes to offerings by business development companies (BDCs). Harry Pangas in Washington DC has deep experience representing BDCs, registered closed-end funds, interval funds, and tender offer funds. Boston-based Thomas Friedmann has a strong track record advising issuers and investment banks on public and private securities transactions. He also advises alternative asset managers on accessing capital via BDCs and closed-end funds, among other vehicles. Stephen Leitzell in Philadelphia is noted particularly for his work in the healthcare and tech sectors. The three partners lead the group along with New York-based Anna Tomczyk, whose varied practice spans Rule 144A and Reg S offerings, among other kinds. David Rosenthal is active in the life sciences space. Washington DC’s Matthew Carter is also a key contact in the group.
Legal 500 Editorial commentary
- Profile
- Social
Key clients
- Aquestive Therapeutics
- B&G Foods
- Bain Capital Specialty Finance
- BC Partners
- BioAtla
- Blackstone
- Business Development Company of America
- Diffusion Therapeutics
- EaglePoint Credit Company
- FS Investment Corporation
Work highlights
Advising Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc., a subsidiary of Select Medical, in connection with the contemplated spin-off of Concentra from Select Medical.
Represented Crown Holdings, Inc. (“Crown”) in connection with an offering by Crown European Holdings S.A. (the “Issuer”), a subsidiary of the Company, of €600 million of senior unsecured notes due 2030.
Represented Apollo Debt Solutions BDC in its offering of US$650 million in aggregate principal amount of its 6.900% notes due 2029 in a private placement and in connection with its US$600 million 6.70% investment-grade 144A bond offering.
Lawyers
Practice head
Harry Pangas; Thomas Friedmann; Stephen Leitzell; Anna Tomczyk
Other key lawyers
Matthew Carter; David Rosenthal